Literature DB >> 21233676

Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters.

Cláudia Malheiros Coutinho-Camillo1, Silvia Vanessa Lourenço, Francisco Paulo da Fonseca, Fernando Augusto Soares.   

Abstract

AIMS: Claudins, a large family of essential tight junction (TJ) proteins, are abnormally regulated in human carcinomas. The aim of this study was to determine the expression of claudins 1, 2, 3, 4, 5, 7, and 11 in prostate samples from Brazilian patients and correlate it with the clinicopathological features of prostate cancer.
METHODS: Using a tissue microarray (TMA) of specimens of prostate adenocarcinoma and benign prostatic hyperplasia (BPH) we analysed the expression of claudins 1, 2, 3, 4, 5, 7, and 11 by immunohistochemistry.
RESULTS: Claudin 4 was down-regulated and claudins 2, 3, and 5 were overexpressed in prostate adenocarcinomas compared with BPH samples. Expression of claudins 1 and 7 was similar in tumours and BPH samples. Claudin 11 was absent from all prostate samples. Overexpression of claudin 3 was associated with perineural invasion (p = 0.014) and tended to occur in advanced stages of the disease (p = 0.064). Increased expression of claudin 5 was marginally associated with perineural invasion (p = 0.060).
CONCLUSIONS: Our results suggest that alterations in claudin expression occur in prostate cancer cells, although we have not found an association with the main clinicopathological parameters.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233676     DOI: 10.1097/PAT.0b013e3283428099

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.

Authors:  Thomas Stefan Worst; Jost von Hardenberg; Julia Christina Gross; Philipp Erben; Martina Schnölzer; Ingrid Hausser; Peter Bugert; Maurice Stephan Michel; Michael Boutros
Journal:  Mol Cell Proteomics       Date:  2017-04-09       Impact factor: 5.911

2.  Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.

Authors:  Astrid Escudero-Esparza; Wen G Jiang; Tracey A Martin
Journal:  J Exp Clin Cancer Res       Date:  2012-05-04

Review 3.  Claudin-5: gatekeeper of neurological function.

Authors:  Chris Greene; Nicole Hanley; Matthew Campbell
Journal:  Fluids Barriers CNS       Date:  2019-01-29

4.  Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.

Authors:  Irene M Shui; Chao-Jen Wong; Shanshan Zhao; Suzanne Kolb; Ericka M Ebot; Milan S Geybels; Rohina Rubicz; Jonathan L Wright; Daniel W Lin; Brandy Klotzle; Marina Bibikova; Jian-Bing Fan; Elaine A Ostrander; Ziding Feng; Janet L Stanford
Journal:  Cancer       Date:  2016-05-03       Impact factor: 6.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.